Lord, Abbett & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-411,200
Closed -$8.25M 654
2020
Q4
$8.25M Sell
411,200
-362,515
-47% -$7.59M 0.02% 559
2020
Q3
$18.9M Buy
+773,715
New +$18.1M 0.06% 387
2019
Q2
Sell
-1,007,275
Closed -$24M 779
2019
Q1
$24M Buy
+1,007,275
New +$23M 0.08% 377
2018
Q1
Sell
-818,178
Closed -$24.9M 847
2017
Q4
$24.9M Buy
818,178
+3,003
+0.4% +$79.9K 0.07% 417
2017
Q3
$19.8M Sell
815,175
-2,091,545
-72% -$55.7M 0.06% 479
2017
Q2
$71.6M Sell
2,906,720
-64,939
-2% -$1.37M 0.21% 140
2017
Q1
$64.4M Sell
2,971,659
-1,792,610
-38% -$36.5M 0.19% 158
2016
Q4
$71M Sell
4,764,269
-1,207,108
-20% -$17.4M 0.22% 136
2016
Q3
$76.4M Buy
5,971,377
+3,066,155
+106% +$33.2M 0.23% 120
2016
Q2
$22.7M Buy
+2,905,222
New +$16.7M 0.07% 387

Other funds holding EXEL

Lord, Abbett & Co's EXEL Position: Q1 2021 in Review

Lord, Abbett & Co sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 411,200 shares — an estimated $8.25M sold.

Lord, Abbett & Co first reported a position in EXEL in Q2 2016 and held it in 10 quarters. The position peaked at $76.4M in Q3 2016. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • Lord, Abbett & Co reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 411,200 Exelixis shares in Q1 2021, an estimated $8.25M.
  • Lord, Abbett & Co first reported a position in Exelixis in Q2 2016 and held it in 10 quarters.
  • Lord, Abbett & Co's Exelixis position peaked at $76.4M in Q3 2016.
  • 347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on Lord, Abbett & Co's 13F filing for Q1 2021, filed 11 May 2021.